When Life-Sustaining Treatment Is Withdrawn and the Patient Doesn't Die.

Department of Neonatology, Oslo University Hospital Ulleval, Oslo, Norway
PEDIATRICS (Impact Factor: 5.3). 10/2013; DOI: 10.1542/peds.2013-0413
Source: PubMed

ABSTRACT One of the most difficult decisions that doctors and parents must make is the decision to withdraw life-sustaining treatment. Doctors find it easier to withdraw treatments in situations where withdrawal will be rapidly fatal rather than in situations in which treatment withdrawal will lead to a prolonged dying process. Mechanical ventilation is usually such a treatment. Withdrawal of ventilation generally leads to the patient's rapid demise. Doctors may tell parents that death will occur quickly after a ventilator is withdrawn. But what happens when the doctors are wrong and a patient survives without life support? What should doctors do next? We present a case in which that happened and asked 3 experts to comment on the case. Stefan Kutzsche is a senior consultant in neonatology at Oslo University Hospital Ulleval in Norway. John Colin Partridge is a neonatologist and professor of pediatrics at University of California, San Francisco. Steven R. Leuthner is a neonatologist and professor of pediatrics and bioethics at the Medical College of Wisconsin. They each recommend slightly different approaches to this dilemma.

  • [Show abstract] [Hide abstract]
    ABSTRACT: In clinical practice, and in the medical literature, severe congenital malformations such as trisomy 18, anencephaly, and renal agenesis are frequently referred to as ‘lethal’ or as ‘incompatible with life’. However, there is no agreement about a definition of lethal malformations, nor which conditions should be included in this category. Review of outcomes for malformations commonly designated ‘lethal’ reveals that prolonged survival is possible, even if rare. This article analyses the concept of lethal malformations and compares it to the problematic concept of ‘futility’. We recommend avoiding the term ‘lethal’ and suggest that counseling should focus on salient prognostic features instead. For conditions with a high chance of early death or profound impairment in survivors despite treatment, perinatal and neonatal palliative care would be ethical. However, active obstetric and neonatal management, if desired, may also sometimes be appropriate.
    Seminars in Fetal and Neonatal Medicine 09/1914; In Press-Corrected Proof(5). · 3.13 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To review the role of pediatric palliative care (PPC) for children with metabolic and neurological diseases.
    Current Opinion in Supportive and Palliative Care 07/2014;


Available from
May 27, 2014